{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T15:05:24Z","timestamp":1771081524233,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijcard.2025.134145","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T16:15:07Z","timestamp":1768061707000},"page":"134145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cardiac remodeling and arterial stiffness progression in wild-type vs hereditary transthyretin amyloidosis in Crete"],"prefix":"10.1016","volume":"449","author":[{"given":"Dafni","family":"Korela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Foukarakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Zaganas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minas","family":"Drakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anth\u03bfula","family":"Plevritaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyros","family":"Maragkoudakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Patrianakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Kapsoritakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Koukouraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Bourogianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalampos","family":"Pontikoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Psillaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen A.","family":"Padadaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Samonakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstathios","family":"Detorakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Petrakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Chlouverakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Giannakoudakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneta","family":"Aleksova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Simantirakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Kochiadakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Marketou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2025.134145_bb0005","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.134145_bb0010","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jaccao.2021.07.002","article-title":"Genomic screening for pathogenic transthyretin variants finds evidence of underdiagnosed amyloid cardiomyopathy from health records","volume":"3","author":"Carry","year":"2021","journal-title":"JACC. CardioOncol."},{"key":"10.1016\/j.ijcard.2025.134145_bb0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1258\/acb.2011.011225","article-title":"Amyloidosis","volume":"49","author":"Pinney","year":"2012","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ijcard.2025.134145_bb0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/HCO.0000000000000547","article-title":"Amyloidosis cardiomyopathy: update in the diagnosis and treatment of the most common types","volume":"33","author":"Nativi-Nicolau","year":"2018","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.ijcard.2025.134145_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292435","article-title":"Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the transthyretin amyloidosis outcomes survey (THAOS)","volume":"19","author":"Gentile","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2025.134145_bb0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/13506129.2020.1830272","article-title":"DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis: a comment","volume":"28","author":"Barrenechea","year":"2021","journal-title":"Amyloid"},{"key":"10.1016\/j.ijcard.2025.134145_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70057","article-title":"Hereditary transthyretin amyloidosis in Israel: genetic landscape and clinical characteristics","volume":"32","author":"Dori","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ijcard.2025.134145_bb0040","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200013","article-title":"High hereditary transthyretin-related amyloidosis prevalence in Crete: genetic heterogeneity and distinct phenotypes","volume":"8","author":"Tzagournissakis","year":"2022","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.ijcard.2025.134145_bb0045","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.nmd.2021.09.008","article-title":"Variant transthyretin amyloidosis (ATTRv) polyneuropathy in Greece: a broad overview with a focus on non-endemic unexplored regions of the country","volume":"31","author":"Koutsis","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ijcard.2025.134145_bb0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","article-title":"Cardiac amyloidosis: the great pretender","volume":"20","author":"Rapezzi","year":"2015","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcard.2025.134145_bb0055","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"Gertz","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2025.134145_bb0060","first-page":"25","article-title":"Transthyretin amyloidosis cardiomyopathy in Greece: clinical insights from the National Referral Center","volume":"79","author":"Bampatsias","year":"2024","journal-title":"Hell. J. Cardiol."},{"key":"10.1016\/j.ijcard.2025.134145_bb0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2025.134145_bb0070","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2025.134145_bb0075","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/ehjci\/jex244","volume":"18","author":"Galderisi","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2025.134145_bb0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13023-022-02359-w","article-title":"Clinical and genetic profile of patients enrolled in the transthyretin amyloidosis outcomes survey (THAOS): 14-year update","volume":"17","author":"Dispenzieri","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ijcard.2025.134145_bb0085","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/eurheartj\/ehz173","article-title":"Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the transthyretin amyloidosis outcomes survey (THAOS)","volume":"43","author":"Damy","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.134145_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173086","article-title":"Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - report from the transthyretin amyloidosis outcome survey (THAOS)","volume":"12","author":"Kristen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2025.134145_bb0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (transthyretin amyloid outcome survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2025.134145_bb0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2967\/jnmt.120.261893","article-title":"Global and regional variations in transthyretin cardiac amyloidosis: a comparison of longitudinal strain and 99mTc-pyrophosphate imaging","volume":"50","author":"Lee","year":"2021","journal-title":"J. Nucl. Med. Technol."},{"key":"10.1016\/j.ijcard.2025.134145_bb0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13023-023-02962-5","article-title":"A 15-year consolidated overview of data in over 6000 patients from the transthyretin amyloidosis outcomes survey (THAOS)","volume":"18","author":"Gentile","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ijcard.2025.134145_bb0110","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41431-022-01235-2","article-title":"Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in Central Italy","volume":"31","author":"Mazzarotto","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ijcard.2025.134145_bb0115","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/acn3.51741","article-title":"Ser77Tyr transthyretin amyloidosis in Israel: initial manifestations and diagnostic features","volume":"10","author":"Dori","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ijcard.2025.134145_bb0120","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1292\/jvms.53.1037","article-title":"Pathological studies on cerebral amyloid angiopathy, senile plaques and amyloid deposition in visceral organs in aged dogs","volume":"53","author":"Uchida","year":"1991","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.ijcard.2025.134145_bb0125","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3390\/jcm14062078","article-title":"Deterioration of myocardial global longitudinal strain and its relationship with arterial stiffness in patients with cardiac amyloidosis: a six-month follow-up","volume":"14","author":"Korela","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2025.134145_bb0130","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/jcm14051538","article-title":"One-year echocardiographic follow-up in transthyretin cardiac amyloidosis: impact of tafamidis treatment","volume":"14","author":"Restelli","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2025.134145_bb0135","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1002\/ehf2.14815","article-title":"Impact of tafamidis on myocardial function and CMR tissue characteristics in transthyretin amyloid cardiomyopathy","volume":"11","author":"Dobner","year":"2024","journal-title":"ESC Heart. Fail."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732501188X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732501188X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T14:17:53Z","timestamp":1771078673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752732501188X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":27,"alternative-id":["S016752732501188X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.134145","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac remodeling and arterial stiffness progression in wild-type vs hereditary transthyretin amyloidosis in Crete","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.134145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"134145"}}